At Owlpharma we are already preparing 2024 maintaining our approach of continuous improvement and development of new capabilities to be ready to meet the expectations of our customers providing high-quality services for the whole Pharma and Health care industries.

‍

2023 was a debut year for Owlpharma’s Audits department but not a quiet one. We have successfully launched our audit reports & planning platform, AuditSearch and we were all around the world (and sometimes remotely) executing audits on behalf of our partners.

‍

We have executed audits across different scopes, including GMP/GDP/ISO 9001:2015 Audits, Pharmacovigilance audits and audits to MA Dossiers. Taking advantage of the combined expertise of our departments and auditors, we were able to also execute cross-functional audits and cover multiple scopes within the same audit process.

‍

Now, as a next step in our journey through the compliance world we have successfully trained our team who developed a robust process for GCP Auditing. We are glad to inform that we are currently able to assist you in the execution of the following types of audits:

• Investigator Site Audits;
• Sponsors and IMP Manufacturers’ audits;
• Critical Document Audits (e.g. Clinical Trial protocol, Case Report Forms, etc.);
• Audits to Third Parties.

‍

If you need any additional clarification or support, let us know.

‍

We are here to keep your business running.

‍